Business

Nestle secures peanut allergy treatment

Published on 1 Sep 2020 3:55:20 PM

Nestle will pay US$2 billion to buy the remaining stake in Aimmune Therapeutics Inc, gaining full ownership of the first US-approved peanut allergy treatment.

WATCH MORE: https://thestartv.com/c/news
SUBSCRIBE: https://cutt.ly/TheStar
LIKE: https://fb.com/TheStarOnline